These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 33219488)
1. Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas: identifying predictors of 50% volume reduction. Hongyo H; Higashihara H; Osuga K; Kashiwagi E; Kosai S; Nagai K; Tanaka K; Ono Y; Ujike T; Uemura M; Imamura R; Nonomura N; Tomiyama N CVIR Endovasc; 2020 Nov; 3(1):84. PubMed ID: 33219488 [TBL] [Abstract][Full Text] [Related]
2. Sporadic versus Tuberous Sclerosis Complex-Associated Angiomyolipomas: Predictors for Long-Term Outcomes following Transcatheter Embolization. Sheth RA; Feldman AS; Paul E; Thiele EA; Walker TG J Vasc Interv Radiol; 2016 Oct; 27(10):1542-9. PubMed ID: 27522275 [TBL] [Abstract][Full Text] [Related]
3. Prophylactic embolization of renal angiomyolipomas: evaluation of therapeutic response using CT 3D volume calculation and density histograms. Planché O; Correas JM; Mader B; Joly D; Méjean A; Hélénon O J Vasc Interv Radiol; 2011 Oct; 22(10):1388-95. PubMed ID: 21757371 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic selective arterial embolization for renal angiomyolipomas: efficacy and evaluation of predictive factors of significant shrinkage. Lin L; Wang C; Pei R; Guan H; Wang J; Yang M; Tong X; Zou Y Int Urol Nephrol; 2018 Oct; 50(10):1765-1770. PubMed ID: 30101376 [TBL] [Abstract][Full Text] [Related]
5. Superselective Transcatheter Arterial Embolization for Large Unruptured Renal Angiomyolipoma in Lymphangioleiomyomatosis. Kato H; Kuwatsuru R; Inoue T; Okada S; Aida M; Yamashiro Y J Vasc Interv Radiol; 2018 Jul; 29(7):958-965. PubMed ID: 29398412 [TBL] [Abstract][Full Text] [Related]
6. Transcatheter Arterial Embolization for Renal Angiomyolipoma Using a Micro-balloon Catheter and a Mixture of Ethanol and Lipiodol. Sawada Y; Shimohira M; Hashizume T; Sobue R; Mori S; Nakagawa M; Ozawa Y; Naiki T; Nagai T; Yasui T; Shibamoto Y Cardiovasc Intervent Radiol; 2017 Dec; 40(12):1933-1939. PubMed ID: 28685379 [TBL] [Abstract][Full Text] [Related]
7. Safety, Efficacy and Mid-Term Outcome for Transarterial Embolization (TAE) of Renal Angiomyolipoma (AML) Using Ethylene Vinyl Alcohol Copolymer Liquid Embolic Agent (EVOH). Rolland R; Loubet A; Bommart S; Monnin-Bares V; Zarqane H; Vanoverschelde J; Herman F; Molinari N; Kovacsik H J Clin Med; 2023 May; 12(10):. PubMed ID: 37240490 [TBL] [Abstract][Full Text] [Related]
8. Use of microspheres in embolization for unruptured renal angiomyolipomas. Shimohira M; Nagai K; Ohta K; Sawada Y; Naiki T; Nagai T; Yasui T; Shibamoto Y Open Med (Wars); 2021; 16(1):655-659. PubMed ID: 33977148 [TBL] [Abstract][Full Text] [Related]
9. Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction. Bardin F; Chevallier O; Bertaut A; Delorme E; Moulin M; Pottecher P; Di Marco L; Gehin S; Mourey E; Cormier L; Mousson C; Midulla M; Loffroy R Quant Imaging Med Surg; 2017 Feb; 7(1):8-23. PubMed ID: 28275556 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic renal artery embolization before pregnancy in patients with lymphangioleiomyomatosis and renal angiomyolipoma. Toei H; Zhang X; Seyama K; Yashiro D; Kuwatsuru Y; Kuwatsuru R J Int Med Res; 2022 Sep; 50(9):3000605221123897. PubMed ID: 36124884 [TBL] [Abstract][Full Text] [Related]
11. Can we predict the existence of extrarenal feeders to renal angiomyolipomas? Zhang X; Kuwatsuru R; Toei H; Yashiro D; Okada S; Kato H Eur Radiol; 2019 May; 29(5):2499-2506. PubMed ID: 30542748 [TBL] [Abstract][Full Text] [Related]
12. Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis. Sheth RA; Feldman AS; Paul E; Thiele EA; Walker TG World J Radiol; 2016 Mar; 8(3):308-15. PubMed ID: 27027863 [TBL] [Abstract][Full Text] [Related]
13. Effect of everolimus treatment for regrown renal angiomyolipoma associated with tuberous sclerosis complex after transcatheter arterial embolization. Hatano T; Matsu-Ura T; Mori KI; Inaba H; Endo K; Tamari M; Egawa S Int J Clin Oncol; 2018 Dec; 23(6):1134-1139. PubMed ID: 30069798 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex. Ewalt DH; Diamond N; Rees C; Sparagana SP; Delgado M; Batchelor L; Roach ES J Urol; 2005 Nov; 174(5):1764-6. PubMed ID: 16217279 [TBL] [Abstract][Full Text] [Related]
16. Embolization of renal angiomyolipomas: short-term and long-term outcomes, complications, and tumor shrinkage. Lee SY; Hsu HH; Chen YC; Huang CC; Wong YC; Wang LJ; Chuang CK; Yang CW Cardiovasc Intervent Radiol; 2009 Nov; 32(6):1171-8. PubMed ID: 19572171 [TBL] [Abstract][Full Text] [Related]
17. Laparoscopic cryoablation of angiomyolipomas in adolescents and young adults: A report of four cases associated with tuberous sclerosis and 1 case of sporadic origin. Trelborg K; Nielsen TK; Østraat EØ; Olsen LH J Pediatr Urol; 2016 Dec; 12(6):384.e1-384.e6. PubMed ID: 27346068 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of cannabidiol on renal angiomyolipoma and subependymal giant cell tumor volume in tuberous sclerosis complex. Barnett JR; Grinspoon RA; Harisinghani M; Caruso PA; Thiele EA J Clin Neurosci; 2020 Jul; 77():85-88. PubMed ID: 32409220 [TBL] [Abstract][Full Text] [Related]